# A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease

> **NCT00744276** · PHASE2 · COMPLETED · sponsor: **FemmePharma Global Healthcare, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Fibrocystic Disease of Breast

## Interventions

- **DRUG:** danazol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00744276
- **Lead sponsor:** FemmePharma Global Healthcare, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-04
- **Final completion:** 2009-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2010-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00744276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00744276, "A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00744276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*